Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Kotb

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Infection|October 19, 2005
Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis COlivier Lambotte, Moana Gelu-Simeon, Gwenola Maigne, et al.
European Journal of Haematology|February 3, 2006
Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's diseaseRami Kotb, Isabelle Vincent, Anne Dulioust, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline ConsortiumDebra J Bergstrom, Rami Kotb, Martha L Louzada, et al.
European Journal of Haematology|June 11, 2005
Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary studyRami Kotb, Caroline Pinganaud, Catherine Trichet, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline ConsortiumJulie Côté, Rami Kotb, Debra J Bergstrom, et al.
Journal of Cellular Physiology|March 19, 2016
XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor CellsCheryl Taylor-Kashton, Daniel Lichtensztejn, Erkan Baloglu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 28, 2023
Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomesChantal Tian, Brittany Perija, Rami Kotb, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 28, 2020
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world settingMarc Geirnaert, Jacy Howarth, Kristen Martin, et al.
Journal of the American Geriatrics Society|October 3, 2007
Acquired hemophilia in older people: a poor prognosis despite intensive careOlivier Lambotte, Justine Dautremer, Benoît Guillet, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline ConsortiumSahar Khan, Debra J Bergstrom, Julie Côté, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Infection|October 19, 2005
Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis COlivier Lambotte, Moana Gelu-Simeon, Gwenola Maigne, et al.
European Journal of Haematology|February 3, 2006
Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's diseaseRami Kotb, Isabelle Vincent, Anne Dulioust, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline ConsortiumDebra J Bergstrom, Rami Kotb, Martha L Louzada, et al.
European Journal of Haematology|June 11, 2005
Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary studyRami Kotb, Caroline Pinganaud, Catherine Trichet, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline ConsortiumJulie Côté, Rami Kotb, Debra J Bergstrom, et al.
Journal of Cellular Physiology|March 19, 2016
XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor CellsCheryl Taylor-Kashton, Daniel Lichtensztejn, Erkan Baloglu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 28, 2023
Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomesChantal Tian, Brittany Perija, Rami Kotb, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 28, 2020
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world settingMarc Geirnaert, Jacy Howarth, Kristen Martin, et al.
Journal of the American Geriatrics Society|October 3, 2007
Acquired hemophilia in older people: a poor prognosis despite intensive careOlivier Lambotte, Justine Dautremer, Benoît Guillet, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline ConsortiumSahar Khan, Debra J Bergstrom, Julie Côté, et al.
Pageof 7